SBIR resubmissions are still allowed, but success depends on correcting reviewer concerns, not simply revising language or adding more detail.
Archives
What “Competitive But Not Discussed” Really Signals in NIH Review, and What to Do With It
NIH’s “competitive but not discussed” designation reflects review compression, not automatic rejection, and still carries real funding potential.